Spot Trading’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$9.26M Sell
145,200
-103,400
-42% -$6.04M 0.16% 118
2017
Q2
$13.9M Buy
248,600
+128,600
+107% +$7M 0.27% 39
2017
Q1
$6.53M Buy
120,000
+43,500
+57% +$2.39M 0.22% 61
2016
Q4
$4.47M Buy
76,500
+14,900
+24% +$815K 0.1% 233
2016
Q3
$3.32M Sell
61,600
-16,700
-21% -$1.07M 0.07% 419
2016
Q2
$5.76M Sell
78,300
-153,300
-66% -$10.8M 0.1% 257
2016
Q1
$14.8M Buy
231,600
+152,900
+194% +$9.64M 0.26% 56
2015
Q4
$5.41M Sell
78,700
-12,800
-14% -$846K 0.06% 461
2015
Q3
$5.42M Sell
91,500
-45,800
-33% -$2.91M 0.05% 475
2015
Q2
$9.14M Buy
137,300
+65,700
+92% +$4.33M 0.08% 297
2015
Q1
$4.62M Buy
71,600
+44,500
+164% +$2.79M 0.05% 602
2014
Q4
$1.6M Sell
27,100
-30,800
-53% -$1.74M 0.01% 1578
2014
Q3
$2.96M Buy
57,900
+6,900
+14% +$345K 0.01% 1270
2014
Q2
$2.47M Sell
51,000
-521,600
-91% -$25.7M 0.01% 1483
2014
Q1
$29.7M Buy
572,600
+470,600
+461% +$25M 0.17% 104
2013
Q4
$5.42M Sell
102,000
-268,800
-72% -$13.7M 0.03% 807
2013
Q3
$17.2M Buy
370,800
+274,800
+286% +$12.1M 0.11% 171
2013
Q2
$4.29M Buy
+96,000
New +$4.17M 0.03% 809

Other funds holding BMY

Spot Trading's BMY Position: Q3 2017 in Review

Spot Trading reduced its Bristol-Myers Squibb (BMY) stake by 80% in Q3 2017, selling an estimated $8.44M and leaving 36,605 shares worth $2.33M. The position accounts for 0.04% of the portfolio, ranked #641.

Spot Trading first reported a position in BMY in Q2 2013 and has held it in 15 quarters since. The position peaked at $10.1M in Q2 2017. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • Spot Trading held 36,605 shares of Bristol-Myers Squibb worth $2.33M as of Q3 2017.
  • Spot Trading sold 144,522 Bristol-Myers Squibb shares in Q3 2017, an estimated $8.44M.
  • Bristol-Myers Squibb made up 0.04% of Spot Trading's portfolio in Q3 2017, its #641 holding.
  • Spot Trading first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 15 quarters since.
  • Spot Trading's Bristol-Myers Squibb position peaked at $10.1M in Q2 2017.
  • 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.